New England Homes For The Deaf, Inc in Danvers, MA

New England Homes For The Deaf, Inc is a medicare and medicaid certified nursing home in Danvers, Massachusetts. It is located in Essex county at 154 Water Street, Danvers, Massachusetts 01923. You can reach out to the office of New England Homes For The Deaf, Inc via phone at (978) 774-0445. This skilled nursing facility has 30 federally certified beds with average occupancy rate of 87%. Its legal business name is New England Homes For The Deaf and has the following ownership type - Non Profit - Corporation.

New England Homes For The Deaf, Inc (Medicare CCN 225768) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 2004 (20 years certified) and the last quality survey was conducted in November, 2019.

Name	New England Homes For The Deaf, Inc
Location	154 Water Street, Danvers, Massachusetts
Certified By	Medicare and Medicaid
No. of Certified Beds	30
Occupancy Rate	87%
Medicare ID (CCN)	225768
Legal Business Name	New England Homes For The Deaf
Ownership Type	Non Profit - Corporation

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with New England Homes For The Deaf, Inc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.
Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for New England Homes For The Deaf, Inc are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care New England Homes For The Deaf, Inc give to their patients.

Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that RHB-204 has been granted Fast Track designation by the U.S. Food and Drug Administration for its development as a potential first-line, stand-alone, oral treatment of pulmonary nontuberculous mycobacteria (NTM) disease caused by Mycobacterium avium Complex (MAC) - a rare disease for which there is no FDA-approved first-line therapy.

Telemedicine abortions offer cheaper options but may also undermine critical clinics

Allison Hansen had just gone through a breakup with her boyfriend last year when she discovered she was pregnant. She already had an 8-year-old son and did not want another child.

Study evaluates long-acting HIV therapy in patients unable to adhere to strict daily regimens

A clinical trial to evaluate long-acting antiretroviral therapy for maintaining HIV suppression in people for whom adhering to conventional daily oral ART has been a challenge has begun at research sites across the United States.

Vaccination campaign led HBV to more than double rate of "breakout" mutations

A universal infant vaccination campaign in China has led the Hepatitis B virus (HBV) to more than double its rate of "breakout" mutations. These mutations may enable the virus to elude the vaccine, necessitating new vaccination strategies.

Read more Medical News

› Verified 2 days ago

Number of Facility Reported Incidents	0
Number of Substantiated Complaints	0
Number of Fines	0
Total Amount of Fines in Dollars	$0
Number of Payment Denials	0
Total Number of Penalties	0

The resident survey data of New England Homes For The Deaf, Inc is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience Measure	Provider	National Avg.
Percentage of long-stay residents whose need for help with daily activities has increased	15.79	14.46
Percentage of long-stay residents who lose too much weight	7.89	5.51